Citation: L. Langmead et Ds. Rampton, Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers, ALIM PHARM, 15(9), 2001, pp. 1239-1252
Citation: Da. Israel et Rm. Peek, Review article: pathogenesis of Helicobacter pylori-induced gastric inflammation, ALIM PHARM, 15(9), 2001, pp. 1271-1290
Authors:
Redstone, HA
Barrowman, N
van Zanten, SJO
Citation: Ha. Redstone et al., H-2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials, ALIM PHARM, 15(9), 2001, pp. 1291-1299
Authors:
Beaugerie, L
Berenbaum, F
Berrebi, D
Gendre, JP
Prier, A
Kaplan, G
Chatelet, FP
Citation: L. Beaugerie et al., Chronic use of non-steroidal anti-inflammatory drugs does not alter colonic mucosa of patients without diarrhoea, ALIM PHARM, 15(9), 2001, pp. 1301-1306
Authors:
Actis, GC
Bresso, F
Astegiano, M
Demarchi, B
Sapone, N
Boscaglia, C
Rizzetto, M
Citation: Gc. Actis et al., Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis, ALIM PHARM, 15(9), 2001, pp. 1307-1311
Authors:
Reinisch, W
Nahavandi, H
Santella, R
Zhang, Y
Gasche, C
Moser, G
Waldhor, T
Gangl, A
Vogelsang, H
Knobler, R
Citation: W. Reinisch et al., Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study, ALIM PHARM, 15(9), 2001, pp. 1313-1322
Authors:
Carty, E
Rampton, DS
Schneider, H
Rutgeerts, P
Wright, JP
Citation: E. Carty et al., Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's disease, ALIM PHARM, 15(9), 2001, pp. 1323-1329
Authors:
Green, JRB
Lobo, AJ
Giaffer, M
Travis, S
Watkins, HC
Citation: Jrb. Green et al., Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules, ALIM PHARM, 15(9), 2001, pp. 1331-1341
Authors:
Galmiche, JP
Zerbib, F
Ducrotte, P
Fournet, J
Rampal, P
Avasthy, N
Humphries, TJ
Citation: Jp. Galmiche et al., Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole, ALIM PHARM, 15(9), 2001, pp. 1343-1350
Authors:
Xue, S
Katz, PO
Banerjee, P
Tutuian, R
Castell, DO
Citation: S. Xue et al., Bedtime H-2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors, ALIM PHARM, 15(9), 2001, pp. 1351-1356
Authors:
Trudgill, NJ
Hussain, FN
Moustafa, M
Ajjan, R
D'Amato, M
Riley, SA
Citation: Nj. Trudgill et al., The effect of cholecystokinin antagonism on postprandial lower oesophagealsphincter function in asymptomatic volunteers and patients with reflux disease, ALIM PHARM, 15(9), 2001, pp. 1357-1364
Authors:
Robinson, M
Rodriguez-Stanley, S
Ciociola, AA
Filinto, J
Zubaidi, S
Miner, PB
Gardner, JD
Citation: M. Robinson et al., Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn, ALIM PHARM, 15(9), 2001, pp. 1365-1374
Authors:
Netzer, P
Gut, A
Brundler, R
Gaia, C
Halter, F
Inauen, W
Citation: P. Netzer et al., Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis, ALIM PHARM, 15(9), 2001, pp. 1375-1384
Citation: Wc. Orr et al., The role of age and salivation in acid clearance in symptomatic patients with gastro-oesophageal reflux disease, ALIM PHARM, 15(9), 2001, pp. 1385-1388
Authors:
Mikaeli, J
Fazel, A
Montazeri, G
Yaghoobi, M
Malekzadeh, R
Citation: J. Mikaeli et al., Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia, ALIM PHARM, 15(9), 2001, pp. 1389-1396
Citation: A. Sonnenberg, When William of Ockham meets Thomas Bayes: finding a few diagnoses among agreat many symptoms., ALIM PHARM, 15(9), 2001, pp. 1403-1407
Authors:
Ortiz, JJ
Ayoub, A
Gargala, G
Chegne, NL
Favennec, L
Citation: Jj. Ortiz et al., Randomized clinical study of nitazoxanide compared to metronidazole in thetreatment of symptomatic giardiasis in children from Northern Peru, ALIM PHARM, 15(9), 2001, pp. 1409-1415
Authors:
Battezzati, PM
Zuin, M
Crosignani, A
Allocca, M
Invernizzi, P
Selmi, C
Villa, E
Podda, M
Citation: Pm. Battezzati et al., Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients, ALIM PHARM, 15(9), 2001, pp. 1427-1434
Citation: Sp. Pereira et al., Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile, ALIM PHARM, 15(9), 2001, pp. 1435-1443
Authors:
Buhling, A
Radun, D
Muller, WA
Malfertheiner, P
Citation: A. Buhling et al., Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora, ALIM PHARM, 15(9), 2001, pp. 1445-1452
Authors:
Fennerty, MB
Magaret, N
Dalros, L
Faigel, D
Lieberman, D
Shaw, M
Citation: Mb. Fennerty et al., Outcomes of Helicobacter pylori treatment in community practice and impactof therapeutic effectiveness information on physician behaviour, ALIM PHARM, 15(9), 2001, pp. 1453-1458